Oncology – Eurofins Biomnis
 

 

The Biomnis team has developed significant expertise in the field of biological oncology (biological management of haematological malignancies and solid tumours).

In the field of biochemistry, Biomnis offers the analysis of serum tumour markers by immunoassay or RIA (for the CG-free beta chain and chromogranin A) and urinary (or serum) markers such as catecholamines, metanephrines, VMA, HVA, serotonin, and 5HIIA by HPLC, which constitutes the method of reference for these areas. Free light chain tests are performed during follow-ups on myelomas and monoclonal gammopathies of undetermined significance.

Biomnis was among the first laboratories to introduce the PCA3 test for prostate cancer, and recently developed new biological markers in order to improve the detection of this type of cancer (Index phi using assays on [-2]proPSA, total PSA and free PSA), as well as the early management and follow-up of ovarian cancer (HE-4 and the calculation of the ROMA score).

Focus on
Ovarian cancer HE4 & ROMA score (DS13-INTGB)

Mettez à jour votre navigateur pour consulter ce site

Mettez à jour votre navigateur pour consulter ce site